MCM2 expression in locally advanced hormone receptor-positive HER2 negative (HR+/HER2-) early breast cancer receiving neoadjuvant chemotherapy.

被引：0

作者：

Susiriwatananont, Thiti

Iampenkhae, Kroongpong

Chumsri, Saranya

Parinyanitikul, Napa

机构：

[1] Chulalongkorn Univ, Fac Med, Dept Internal Med, Div Med Oncol, Bangkok, Thailand

[2] King Chulalongkorn Mem Hosp, Bangkok, Thailand

[3] Chulalongkorn Univ, Fac Med, Dept Pathol, Bangkok, Thailand

[4] Mayo Clin Florida, Jacksonville, FL USA

来源：

关键词：

D O I：

10.1200/JCO.2025.43.16_suppl.e12532

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：e12532 / e12532

页数：1